(Q46868361)

English

Intraportally delivered GLP-1, in the presence of hyperglycemia induced via peripheral glucose infusion, does not change whole body glucose utilization

scientific article published on 4 December 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18056788

Intraportally delivered GLP-1, in the presence of hyperglycemia induced via peripheral glucose infusion, does not change whole body glucose utilization (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18056788

0 references

1 reference

based on heuristic

inferred from title

Dale S Edgerton

2

object named as

Dale S Edgerton

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18056788

Alan D. Cherrington

7

object named as

Alan D Cherrington

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18056788

5

object named as

Ben Farmer

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18056788

6

object named as

Doss Neal

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18056788

author name string

Kathryn M S Johnson

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18056788

Tiffany Rodewald

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18056788

Melanie Scott

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18056788

publication date

4 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18056788

American Journal of Physiology - Endocrinology and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18056788

294

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18056788

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18056788

E380-4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18056788

Interaction between insulin and glucose-delivery route in regulation of net hepatic glucose uptake in conscious dogs

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00642.2007

21 January 2018

Importance of the route of intravenous glucose delivery to hepatic glucose balance in the conscious dog

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00642.2007

21 January 2018

Characterization of GLP-1 effects on beta-cell function after meal ingestion in humans

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00642.2007

21 January 2018

Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00642.2007

21 January 2018

Portal glucose infusion in the mouse induces hypoglycemia: evidence that the hepatoportal glucose sensor stimulates glucose utilization.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00642.2007

21 January 2018

Fasting and postprandial concentrations of GLP-1 in intestinal lymph and portal plasma: evidence for selective release of GLP-1 in the lymph system

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00642.2007

21 January 2018

Insulin secretion-independent effects of GLP-1 on canine liver glucose metabolism do not involve portal vein GLP-1 receptors.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00642.2007

21 January 2018

Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00642.2007

21 January 2018

Synergistic effect of portal glucose and glucagon-like peptide-1 to lower systemic glucose and stimulate counter-regulatory hormones.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00642.2007

21 January 2018

Important role of the hepatic vagus nerve in glucose uptake and production by the liver.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00642.2007

21 January 2018

Absence of a memory effect for the insulinotropic action of glucagon-like peptide 1 (GLP-1) in healthy volunteers

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00642.2007

21 January 2018

Intraportal glucose delivery alters the relationship between net hepatic glucose uptake and the insulin concentration

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00642.2007

21 January 2018

Hepatic glucose-sensitive unit regulation of glucose-induced insulin secretion in rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00642.2007

21 January 2018

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00642.2007

21 January 2018

The effect of D-glucose on the firing rate of glucose-sensitive vagal afferents in the liver in comparison with the effect of 2-deoxy-D-glucose

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00642.2007

21 January 2018

Characterization of the portal signal in a nonsteady hyperglycemic state in conscious dogs

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00642.2007

21 January 2018

Comparison of the time courses of insulin and the portal signal on hepatic glucose and glycogen metabolism in the conscious dog.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00642.2007

21 January 2018

Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00642.2007

21 January 2018

Extrapancreatic effects of GIP and GLP-1.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00642.2007

21 January 2018

Identifiers

10.1152/AJPENDO.00642.2007

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18056788

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18056788

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46868361&oldid=2135335386"